Search results

  1. E

    Fatigue in post COVID-19 patients: the P4O2 COVID-19 study, 2023, Maitland-Van der Zee et al

    This is a conference abstract. To the mods: Would it be possible to add "conference abstract" or something similar as tag? I've added this work since Maitland-van der Zee recently received a grant to do LC research in the Netherlands. Some of her other work includes Identification of long...
  2. E

    News from The Netherlands

    4 new grants for Long-Covid research have been announced https://www.zonmw.nl/nl/nieuws/start-post-covid-onderzoek-en-vooraankondiging-subsidieoproepen-onderzoeksprogramma-post. The 4 projects will be: Characterization of aberrant immune response in post-COVID using innovative STP technology...
  3. E

    Fatigue in post COVID-19 patients: the P4O2 COVID-19 study, 2023, Maitland-Van der Zee et al

    Fatigue in post COVID-19 patients: the P4O2 COVID-19 study Abstract Background: Some patients do not fully recover after COVID-19 and have symptoms occurring 3 months after acute illness, lasting for >2 months, defined as post COVID-19. Fatigue seems most present in post COVID-19 and part of...
  4. E

    Profound Symptom Alleviation in Long-Covid Patients After PAMP-Immunotherapy: Three Case Reports, 2023, Hobohm et al

    Thank you for providing some extra context (I certainly believe free access shouldn’t be a compliment, but a necessity). I’m suprised by how quickly all reviews came in for such a questionable paper (9 reviews already within 5 days) do you have some information on how the reviewers are chosen?
  5. E

    Profound Symptom Alleviation in Long-Covid Patients After PAMP-Immunotherapy: Three Case Reports, 2023, Hobohm et al

    Don't think anything useful can be said about three case reports. I had never heard of the website/journal Qeios and the website seems very scammy (very ChatGPT-like) but at least some of the reviews on this paper do actually pose the right kind of questions (some also seem awfully strange)...
  6. E

    Profound Symptom Alleviation in Long-Covid Patients After PAMP-Immunotherapy: Three Case Reports, 2023, Hobohm et al

    Profound Symptom Alleviation in Long-Covid Patients After PAMP-Immunotherapy: Three Case Reports Abstract Background Long-Covid patients suffer from a range of symptoms with a largely varying degree of severity, including chronic fatigue syndrome (CFS), myalgic encephalomyelitis (ME)...
  7. E

    Differential Cardiopulmonary Hemodynamic Phenotypes in PASC Related Exercise Intolerance, 2023, Singh et al

    Is there a meta-analysis on this somewhere that somehow tries to explain all different results? Personally, I feel like the results aren't consistent enough, possibly due to inconsistent methodology, varying cohorts or it not being quite as useful method as some patients believe, possibly...
  8. E

    Prevalence of orthostatic intolerance in long covid clinic patients and healthy volunteers: A multicenter study, 2024, Cassie Lee, Darren

    Cohort characteristics: 277 Long-Covid patients, 50 healthy controls. Contrary to many other studies, this study did very well in terms of not only recruiting elderly people (mean ages LC=48, HC=48) and they also did well w.r.t. sex distribution in their cohorts (62% females in LC vs 64%...
  9. E

    Prevalence of orthostatic intolerance in long covid clinic patients and healthy volunteers: A multicenter study, 2024, Cassie Lee, Darren

    What are you doing UK scientists? You can't just go and measure the heart rate of a patient. You're supposed to gaslight them!
  10. E

    The post-COVID-19 population has a high prevalence of cross-reactive antibodies to spikes from all Orthocoronavirinae genera, 2023, Krammer et al

    The post-COVID-19 population has a high prevalence of cross-reactive antibodies to spikes from all Orthocoronavirinae genera ABSTRACT The Orthocoronavirinae subfamily is large comprising four highly divergent genera. Four seasonal coronaviruses were circulating in humans prior to the...
  11. E

    2023: looking back on a year of ME/CFS research

    That must have been a bit of work! I thought the research by Rob Wüst's team interesting as well (finally someone looking at muscles and metabolites w.r.t. PEM!), even though the majority of it hasn’t been published yet (some of their work was published here and other parts have been discussed...
  12. E

    News from the USA, United States of America

    A letter to President Biden has been signed by Policy experts, scientists and disability groups. The subject is "Address the Crisis of Long COVID and Other Infection-Associated Chronic Conditions in FY25 Budget". The letter can be found here. It might be useful to remember these names for...
  13. E

    Post-Traumatic Stress Disorder and Complex Post-Traumatic Stress Disorder in people with long COVID, ME/CFS, and controls 2023 Sanal-Hayes et al

    Same group that published People With Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Exhibit Similarly Impaired Vascular Function, 2023, McLaughlin+. I don't have access to this paper, but their previous paper didn't mention which diagnostic criteria were being...
  14. E

    BBC Article : Why Covid is still flooring some people

    It’s never about risks being cumulative (especially not with the LC definition that is being used), that’s just a trivial fact that would apply to any viral infection (in fact it applies to any health adverse event and it even applies to non-health adverse events as it applies to simply time...
  15. E

    Risk of Multiple Sclerosis in People Living with HIV: An International Cohort Study, 2023, McKAy et al

    Risk of Multiple Sclerosis in People Living with HIV: An International Cohort Study Abstract Objective There has been interest in a possible negative association between HIV and multiple sclerosis (MS). We aimed to compare the risk of MS in a cohort of individuals living with HIV to that in...
  16. E

    £622,000 grant to improve diagnosis and treatment for ME/CFS and Long Covid

    In Germany there's also a large study called BOSCO which is generally looking at all outcomes to Covid. I can't see whether their classification of Long-Covid is useful enough to reveal anything about Long-Covid, but they at least are looking at it (translated from homepage) "The extent to which...
  17. E

    Long-term outcomes following hospital admission for COVID-19 versus seasonal influenza: a cohort study, 2023, Xie, Al-Aly et al.

    I don't think anybody should be suprised that any health disruption happening to 70 year old males with several comorbidities can bare health consequences. I strongly doubt you'll find any useful answers there though or that it's even anything worth studying in the fashion it's done here...
  18. E

    The Observer/Guardian article: Does the microbiome hold the key to chronic fatigue? About patient led 'research' group Remission Biome.

    Dr.T. : "Important note to my followers and the @remissionbiome community: I am no longer associated with @remissionbiome or Renegade Research. I owe you all an explanation and one will be forthcoming once I have been given the legal go ahead. My mission remains the same as it has always been...
  19. E

    News from Germany

    ME/CFS Research Foundation on Twitter www.twitter.com/MECFSResearch "In 2024, a #MECFS research project will start at ChariteBerlin, which we are jointly funding with the @LostVoicesStiftung. Focus: researching biomarkers and disease mechanisms using an advanced blood analysis method." Details...
  20. E

    USA: The RECOVER Initiative - Long Covid research

    200 million, now that's proper budget with which you can do a tremendous amount of exercise and lifestyle intervention studies.
Back
Top Bottom